Emgality (galcanezumab-gnlm) is the first FDA-approved drug that reduces the frequency of headache attacks.
Headache and Migraine
A new tool to add to your armamentarium?
To kick off Migraine and Headache Awareness Month, the latest findings reported here may influence your approaches to diagnosis, treatment, and prevention and help you keep your patients informed.
Around three times more women than men have migraine. This marked difference in prevalence is one of the most well-known features of the illness. Here's what history tells us.
Cognitive deficits are gender based, opioids complicate prophylactic treatment, patients with migraine seen by ophthalmologists—find concise summaries of these and other findings here.
Women are three times more susceptible to migraine than are men. The difference is so pronounced that men with migraine are at risk for being underdiagnosed and undertreated. Why such a discrepancy?
What's your diagnosis for a 45-year-old woman who experienced strange symptoms after taking an advanced yoga class?
Neurology Times' podcast with a pediatric headache specialist and neurologist who has performed over 1000 procedures to treat migraine in children and adolescents.
Investigators are looking for and finding new approaches to diagnosis, treatment, and prevention. Here: highlights of some of the latest findings.
Take this brief quiz to test your knowledge of recent recommendations from the American Headache Society for the prevention and acute management of migraine.